| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.4 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | -2.3e+02 | 0.4 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |